Article
Obstetrics & Gynecology
Jolyn S. Taylor, Maria D. Iniesta, Andres Zorrilla-Vaca, Katherine E. Cain, Javier D. Lasala, Gabriel E. Mena, Larissa A. Meyer, Pedro T. Ramirez
Summary: This study aimed to evaluate the rate of venous thromboembolism within 30 days of gynecologic surgery on an Enhanced Recovery After Surgery pathway performed at a cancer center. The study found that the rate of venous thromboembolism among patients undergoing laparotomy and minimally invasive surgery on an Enhanced Recovery After Surgery pathway was 1%. This study established a benchmark for the rate of venous thromboembolism after gynecologic surgery on an Enhanced Recovery After Surgery pathway performed at a cancer center.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
(2023)
Article
Oncology
Sarah P. Huepenbecker, Maria D. Iniesta, Andres Zorrilla-Vaca, Pedro T. Ramirez, Katherine E. Cain, Micah Vaughn, Juan P. Cata, Gabriel E. Mena, Javier Lasala, Larissa A. Meyer
Summary: The study revealed that the incidence and odds of postoperative AKI were higher after open gynecologic surgery within ERAS. Patients with AKI were more likely to experience complications, leading to longer hospital stays and increased readmission rates. Potential strategies to prevent postoperative AKI include optimizing perioperative fluid and blood pressure management.
GYNECOLOGIC ONCOLOGY
(2021)
Article
Oncology
G. Nelson, C. Fotopoulou, J. Taylor, G. Glaser, J. Bakkum-Gamez, L. A. Meyer, R. Stone, G. Mena, K. M. Elias, A. D. Altman, S. P. Bisch, P. T. Ramirez, S. C. Dowdy
Summary: This article presents the updated evidence and recommendations for implementing Enhanced Recovery After Surgery (ERAS) in gynecologic oncology surgery. It focuses on addressing implementation challenges and provides evidence-based guidelines.
GYNECOLOGIC ONCOLOGY
(2023)
Article
Oncology
Yinin Hu, Annie W. Hsu, Vivian E. Strong
Summary: This review summarizes recent data relevant to the preoperative, perioperative, and postoperative management of gastrectomy patients along an ERAS pathway.
ANNALS OF SURGICAL ONCOLOGY
(2021)
Review
Medical Laboratory Technology
Arezoo Solati, Sina Thvimi, Seyyed Hossein Khatami, Zahra Shabaninejad, Yalda Malekzadegan, Mehdi Alizadeh, Pegah Mousavi, Mortaza Taheri-Anganeh, Damoun Razmjoue, Sedigheh Bahmyari, Hojat Ghasemnejad-Berenji, Asma Vafadar, Elahe Soltani Fard, Hassan Ghasemi, Ahmad Movahedpour
Summary: Gynecologic cancer refers to tumors affecting the reproductive tissues and organs of women. Recent studies have shown that non-coding RNAs play a crucial role in modulating cellular functions within gynecological cancer, and they may serve as biomarkers and therapeutic agents.
CLINICA CHIMICA ACTA
(2023)
Article
Oncology
V. Bebia, E. Gimenez, M. B. Aller, M. Bradbury, M. A. Perez-Benavente, Y. Cossio-Gil
Summary: The study demonstrates that implementing an ERAS pathway for advanced ovarian cancer patients can reduce length of stay and hospital readmissions, and also lead to cost savings compared to conventional management.
Review
Oncology
Christa Aubrey, Gregg Nelson
Summary: Enhanced recovery after surgery (ERAS) has established benefits in minimally invasive gynecologic oncology surgery, including decreased length of stay, cost-savings, decreased opioid use, and increased patient satisfaction.
Article
Oncology
Chunmei Liu, Wei Gao, Wenjun Meng, Meng Ding, Runsheng Huang, Ya Xiao, Ling Zhou, Sheng Wang, Xin Wei
Summary: The study evaluated the ability of the Tilburg Frailty Indicator (TFI) to predict the quality of post-operative recovery in patients with gynecologic cancer and explored the associations between frailty, post-operative complications, and length of stay. The findings suggest that the TFI assessment can assist surgeons in estimating the risk of post-operative quality of recovery and complications in patients with gynecologic cancer.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
(2023)
Review
Oncology
S. P. Bisch, C. A. Jago, E. Kalogera, H. Ganshorn, L. A. Meyer, P. T. Ramirez, S. C. Dowdy, G. Nelson
Summary: ERAS implementation in gynecologic oncology surgery leads to decreased length of stay, complications, and cost, without increasing readmission or mortality rates.
GYNECOLOGIC ONCOLOGY
(2021)
Review
Medicine, General & Internal
Caroline Tresch, Marine Lallemant, Rajeev Ramanah
Summary: This study aimed to review the influence of enhanced rehabilitation on outcomes of pelvic organ prolapse surgery. The findings showed no significant difference in operating time, complications, blood loss, and pain scores before and after the adoption of the enhanced recovery after surgery (ERAS) program. However, there was a noticeable decrease in intravenous intakes, opioid administration, length of stay, and overall hospital costs with the adoption of ERAS. Patients were also able to mobilize more rapidly and reported higher satisfaction levels.
JOURNAL OF CLINICAL MEDICINE
(2023)
Article
Obstetrics & Gynecology
Yuan Ren, Dawei Sun, Lijian Pei, Xia Liu, Ying Liu, Haiyuan Liu
Summary: The study showed that a full enhanced recovery after surgery (ERAS) program can further improve perioperative outcomes among patients undergoing gynecologic laparoscopic procedures compared to limited ERAS management. Key findings included reduced postoperative length of stay, less pain, faster recovery, and lower narcotic consumption rate in the group receiving full ERAS intervention.
JOURNAL OF MINIMALLY INVASIVE GYNECOLOGY
(2021)
Article
Oncology
Stephanie Alimena, Parisa Fallah, Briana Stephenson, Colleen Feltmate, Sarah Feldman, Kevin M. Elias
Summary: The study aimed to compare differences in ERAS implementation and outcomes by race. It found that fewer non-white women received preadmission education, possibly due to language barriers. However, there were no differences in ERAS compliance, postoperative complications, readmissions, reoperations, and ICU transfers between different races.
GYNECOLOGIC ONCOLOGY
(2023)
Article
Oncology
Alon D. Altman, Alexandre Rozenholc, Lana Saciragic, Xiao-qing Liu, Gregg Nelson
Summary: This study surveyed the implementation of Enhanced Recovery After Surgery (ERAS) guidelines among gynecologic oncology providers in Canada. The results showed an increased uptake of 10 ERAS guideline recommendations, indicating potential improvements in clinical outcomes and healthcare system-level benefits.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
(2022)
Article
Obstetrics & Gynecology
Laurence Bernard, Justin M. McGinnis, Jane Su, Mohammad Alyafi, Delia Palmer, Leonard Potts, Kelly-Lynn Nancekivell, Heidi Thomas, Heather Kokus, Lua R. Eiriksson, Lorraine M. Elit, Waldo G. F. Jimenez, Clare J. Reade, Limor Helpman
Summary: The study evaluated the impact of an ERAS program on gynecologic oncology patients undergoing laparotomy, showing significant reductions in length of stay and overall complication rate, particularly in postoperative infections and cardiovascular complications. There was no significant increase in readmission rate following the implementation of the ERAS program.
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA
(2021)
Article
Oncology
Sue Li, S. Alexandra Bercow, Michele Falzone, Rajeshwari Kalyanaraman, J. Michael Worley, M. Colleen Feltmate, Andrea Pelletier, M. Kevin Elias
Summary: The study aimed to investigate the incidence and risk factors of VTE in patients with advanced epithelial ovarian cancer undergoing first-line therapy, including cytoreductive surgery. It was found that with implementation of an ERAS protocol, the incidence of VTE was reduced, although VTE still occurred during first-line therapy. Further research is needed to explore strategies to reduce VTE risk.
GYNECOLOGIC ONCOLOGY
(2021)
Article
Oncology
Antonella Ravaggi, Angela Gambino, Federico Ferrari, Alessandro Olivari, Laura Zanotti, Chiara Romani, Laura Ardighieri, Paolo Antonelli, Giorgia Garganese, Daniela Gallo, Giovanni Scambia, Eliana Bignotti, Enrico Sartori, Stefano Calza, Franco Odicino
Summary: The study suggests that preoperative sVEGF-D levels may serve as a reliable biomarker for predicting lymph node metastasis and prognosis in VSCC patients, facilitating better clinical/surgical decision-making. A prediction model incorporating sVEGF-D, tumor grade from biopsy, tumor diameter, and lymph node evaluation was able to predict lymph node metastasis.
FRONTIERS IN ONCOLOGY
(2022)
Article
Surgery
Ajith K. Siriwardena
Summary: This study provides a global overview of the management of patients with acute cholecystitis during the early phase of the COVID-19 pandemic. The pandemic led to a decrease in surgical workforce and operating facilities, worse severity of disease, and increased use of conservative management. While the number of patients undergoing cholecystectomy decreased, there was no increase in post-operative mortality.
Review
Obstetrics & Gynecology
Sara Forte, Filippo Alberto Ferrari, Hooman Soleymany Majd, Francesca Cisotto, Federico Ferrari
Summary: The advantages of the application of enhanced recovery after surgery (ERAS) protocols in all surgical branches have been well demonstrated. However, there is a lack of strong evidence from randomized trials and the evidence regarding multimodality treatments is of low grade. The main barriers to the implementation of these protocols in clinical practice include resistance to change, lack of institutional support and financial resources, poor communication and collaboration within the multidisciplinary team, and patient-related barriers. To overcome these problems, several enablers have been identified, such as patient involvement, standardized ERAS protocols, leadership and coordination, teamwork and staff education, financial resources, and recognition of the professionals involved.
CLINICAL AND EXPERIMENTAL OBSTETRICS & GYNECOLOGY
(2023)
Article
Obstetrics & Gynecology
Sherif A. A. Shazly, Pluvio J. J. Coronado, Ercan Yilmaz, Rauf Melekoglu, Hanifi Sahin, Luca Giannella, Andrea Ciavattini, Giovanni Delli Carpini, Jacopo Di Giuseppe, Angel Yordanov, Konstantina Karakadieva, Nevena Milenova Nedelcheva, Mariela Vasileva-Slaveva, Juan Luis Alcazar, Enrique Chacon, Nabil Manzour, Julio Vara, Erbil Karaman, Onur Karaaslan, Latif Hacioglu, Duygu Korkmaz, Cem Onal, Jure Knez, Federico Ferrari, Esraa M. M. Hosni, Mohamed E. E. Mahmoud, Gena M. M. Elassall, Mohamed S. S. Abdo, Yasmin I. I. Mohamed, Amr S. S. Abdelbadie
Summary: The objective of this study was to establish a prognostic model for endometrial cancer that individualizes a risk and management plan based on patient and disease characteristics. Machine learning algorithms were applied to analyze patient and disease characteristics, and three models were developed to predict cancer-specific survival and disease-free survival. The Endometrial Cancer Individualized Scoring System (ECISS) developed in this study showed high accuracy in assessing patient-specific survival probability.
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
(2023)
Review
Endocrinology & Metabolism
Iva Pitner, Mislav Mikus, Marina Sprem Goldstajn, Antonio Simone Lagana, Vito Chiantera, Federico Ferrari, Mohsin Shah, Maurizio Nicola D'Alterio, Salvatore Giovanni Vitale, Stefano Angioni
Summary: The purpose of this narrative review is to summarize the role of progesterone levels in pregnancy outcomes for patients undergoing assisted reproductive technologies. The review found that elevated progesterone levels at different stages of the cycle can have varying effects on pregnancy rates in the in vitro fertilization cycle. Additionally, the review also discussed the differences in interpretation of elevated progesterone levels in normal and poorly responding women.
GYNECOLOGICAL ENDOCRINOLOGY
(2023)
Letter
Biochemistry & Molecular Biology
Giorgio Biasiotto, Mattia Carini, Roberto Bresciani, Fabiana Ferrari
JOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY
(2023)
Article
Medicine, General & Internal
Andreas Zouridis, Kianoush Zarrindej, Joshua Rencher, Christina Pappa, Ammara Kashif, Sarah Louise Smyth, Negin Sadeghi, Alisha Sattar, Stephen Damato, Federico Ferrari, Antonio Simone Lagana, Mostafa Abdalla, Sean Kehoe, Susan Addley, Hooman Soleymani Majd
Summary: High grade endometrioid endometrial cancer (HGEEC) is a heterogeneous group of tumors with unclear prognostic features. Cervical stromal involvement is independently related to recurrence and cancer-related death. The recurrence pattern suggests the potential use of patient-initiated follow-up (PIFU) for HGEEC survivors, especially for patients without cervical involvement and after two years from treatment.
JOURNAL OF CLINICAL MEDICINE
(2023)
Review
Obstetrics & Gynecology
Francesco Marasciulo, Irene Passerini, Anna Fichera, Federico Ferrari, Franco E. Odicino, Federico Prefumo
Summary: Hepatocellular carcinoma is the most common primary malignant liver tumor, which typically occurs in the context of chronic liver disease. Diagnosis and treatment of hepatocellular carcinoma during pregnancy can be challenging, but better maternal outcomes are associated with early diagnosis in high-risk asymptomatic women or through abnormal maternal serum AFP screening.
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA
(2023)
Review
Obstetrics & Gynecology
Irene Passerini, Francesco Marasciulo, Federico Prefumo, Anna Fichera, Nicola Fratelli, Filippo Alberto Ferrari, Federico Ferrari, Franco Odicino
Summary: This systematic review examined the use of cervical ripening double-balloon catheter (CRDBC) for the treatment of cesarean scar pregnancy (CSP). The analysis of 5 studies showed that CRDBC was successful in treating early CSPs, with a low rate of maternal complications.
CLINICAL AND EXPERIMENTAL OBSTETRICS & GYNECOLOGY
(2023)
Article
Oncology
Beatriz Navarro Santana, Esmeralda Garcia-Torralba, David Viveros-Carreno, Juliana Rodriguez, Rene Pareja, Alicia Martin, Sara Forte, Kate J. Krause, J. M. Gonzalez-Martin, Pedro T. Ramirez
Summary: This systematic review assessed the rate of complications associated with hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer surgery and found that there were no significant changes in overall complications over time.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
(2023)
Editorial Material
Biochemistry & Molecular Biology
Antonio Simone Lagana, Federico Ferrari, Donatella Mangione, Fabio Fiorino, Alessandra Vassiliadis, Renato Venezia
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2023)
Review
Medicine, General & Internal
Federico Ferrari, Andrea Salvatore Omodei, Filippo Alberto Ferrari, Hooman Soleymani Majd, Laura Ardighieri, Salvatore Giovanni Vitale, Antonio Simone Lagana, Stefano Angioni, Giuseppe Ciravolo, Franco Odicino
Summary: Mesonephric adenocarcinoma (MA) of the vagina is a rare tumor with limited evidence on diagnosis, treatment, follow-up, and prognosis. A systematic review identified 13 cases, including a case report on laparoscopic management of MA.
JOURNAL OF CLINICAL MEDICINE
(2023)
Review
Medicine, General & Internal
Andrea Etrusco, Antonio Simone Lagana, Vito Chiantera, Amerigo Vitagliano, Ettore Cicinelli, Mislav Mikus, Marina Sprem Goldstajn, Federico Ferrari, Stefano Uccella, Simone Garzon, Sandro Gerli, Alessandro Favilli
Summary: The latest FIGO classification has reclassified type 3 myomas from intramural to submucosal. Hysteroscopic myomectomy is considered the standard treatment for submucosal myomas, but there are no specific guidelines for managing type 3 myomas, and the optimal surgical approach remains uncertain.
JOURNAL OF CLINICAL MEDICINE
(2023)
Article
Microbiology
Elisa Gozzini, Davide Radice, Fabio Bottari, Sara Boveri, Maria Elena Guerrieri, Eleonora Petra Preti, Noemi Spolti, Mariacristina Ghioni, Federico Ferrari, Anna Daniela Iacobone
Summary: This study aimed to explore the impact of HPV genotype richness and cervical dysplasia biodiversity on the progression of precancerous lesions. The findings showed that there is an inverse relationship between the richness of high-risk genotypes and age, as well as histologic grade. The biodiversity index of cervical dysplasias decreased as the histologic grade increased, except for cases of normal histology and adenocarcinoma in situ. Different histologic grades formed distinct clusters with different mean ages and biodiversity indices.